glp 1 microdosing benefits Semaglutide: Weight Loss Plus 6 Potential THE PCCA BLOG | Microdosing
Description
Protein is the most satiating macronutrient, meaning it helps individuals feel fuller for longer periods compared to carbohydrates or fats

A phase 1 trial in healthy male and postmenopausal female volunteers was conducted using single dose and multiple dose groups (134)

Oral Wegovy (Semaglutide Pill) In December 2025, the FDA approved Wegovy in pill form, expanding options for semaglutide weight management

Directions for Future Research: Investigations should focus on confirming the efficacy of tirzepatide in type 1 diabetes, elucidating the neuroprotective potential of GLP-1/GIP dual agonists, optimizing perioperative protocols, and facilitating the clinical translation of novel multi-receptor agonists
